Prognostic and Clinicopathological Significance of Long Non-coding RNA PANDAR Expression in Cancer Patients: A Meta-Analysis

Prognostic and Clinicopathological Significance of Long Non-coding RNA PANDAR Expression in Cancer Patients: A Meta-Analysis

Background: Long non-coding RNA PANDAR is an emerging non-coding RNA mapping to 6p21.2. It underlies metastatic progression and chromosomal instability in a variety of cancers. Despite the fact that recent studies have revealed that lncRNA PANDAR may be a potential prognostic biomarker for patients...

Full description

Bibliographic Details
Main Authors: Lizhi Han, Bo Wang, Ruoyu Wang, Zijian Wang, Song Gong, Guo Chen, Dionne Telemacque, Yong Feng, Weihua Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Oncology
Subjects:
long non-coding RNA (lncRNA)
meta-analysis
cancer
promoter of CDKN1A antisense DNA damage activated RNA (PANDAR)
prognosis
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01337/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01337/full

Similar Items